Takeda Pharmaceutical Co Ltd (TAK)
13.22
-0.09
(-0.68%)
USD |
NYSE |
May 17, 16:00
13.23
+0.01
(+0.08%)
After-Hours: 20:00
Takeda Pharmaceutical Shareholders Equity (Quarterly): 48.05B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 48.05B |
December 31, 2023 | 47.81B |
September 30, 2023 | 47.33B |
June 30, 2023 | 47.80B |
March 31, 2023 | 47.69B |
December 31, 2022 | 47.10B |
September 30, 2022 | 46.47B |
June 30, 2022 | 46.25B |
March 31, 2022 | 46.56B |
December 31, 2021 | 46.33B |
September 30, 2021 | 47.56B |
June 30, 2021 | 47.39B |
March 31, 2021 | 46.89B |
December 31, 2020 | 44.94B |
September 30, 2020 | 44.12B |
June 30, 2020 | 43.56B |
March 31, 2020 | 43.71B |
December 31, 2019 | 44.74B |
September 30, 2019 | 45.07B |
June 30, 2019 | 45.14B |
March 31, 2019 | 46.74B |
December 31, 2018 | 18.47B |
September 30, 2018 | 19.07B |
June 30, 2018 | 18.49B |
March 31, 2018 | 18.80B |
Date | Value |
---|---|
December 31, 2017 | 18.75B |
September 30, 2017 | 18.54B |
June 30, 2017 | 17.98B |
March 31, 2017 | 16.94B |
December 31, 2016 | 17.04B |
September 30, 2016 | 17.97B |
June 30, 2016 | 17.59B |
March 31, 2016 | 17.34B |
December 31, 2015 | 17.42B |
September 30, 2015 | 17.68B |
June 30, 2015 | 17.65B |
March 31, 2015 | 17.80B |
December 31, 2014 | 20.95B |
September 30, 2014 | 22.52B |
June 30, 2014 | 23.55B |
March 31, 2014 | 24.01B |
December 31, 2013 | 22.71B |
September 30, 2013 | 23.33B |
June 30, 2013 | 22.46B |
March 31, 2013 | 24.15B |
December 31, 2012 | 23.98B |
September 30, 2012 | 24.64B |
June 30, 2012 | 23.83B |
March 31, 2012 | 25.60B |
December 31, 2011 | 24.67B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
43.56B
Minimum
Jun 2020
48.05B
Maximum
Mar 2024
46.22B
Average
46.51B
Median
Shareholders Equity (Quarterly) Benchmarks
Astellas Pharma Inc | 10.66B |
Nxera Pharma Co Ltd | 435.31M |
PeptiDream Inc | 264.18M |
Healios KK | 24.45M |
AnGes Inc | 165.52M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 99.82B |
Total Liabilities (Quarterly) | 51.76B |
Debt to Equity Ratio | 0.666 |
Current Ratio | 1.106 |
Net Debt Paydown Yield | 0.32% |